These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9142255

  • 1. Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival.
    Namii Y, Hayashi S, Yokoyama I, Kobayashi T, Yasutomi M, Nagasaka T, Uchida K, Hamada H, Takagi H.
    Transplant Proc; 1997 May; 29(3):1738-9. PubMed ID: 9142255
    [No Abstract] [Full Text] [Related]

  • 2. Effect of CTLA4-Ig gene transfer using adenoviral vector in organ and cell transplantation.
    Hayashi S, Namii Y, Kozima T, Kobayashi T, Yokoyama I, Saito I, Hamada H, Ohtsuka S, Uchida K, Takagi H.
    Transplant Proc; 1997 Jun; 29(4):2212. PubMed ID: 9193596
    [No Abstract] [Full Text] [Related]

  • 3. Local production of CTLA4-Ig by adenoviral-mediated gene transfer to the pancreas induces permanent allograft survival and donor-specific tolerance.
    Liu C, Deng S, Yang Z, Kucher T, Guo F, Gelman A, Chen H, Naji A, Shaked A, Brayman KL.
    Transplant Proc; 1999 Jun; 31(1-2):625-6. PubMed ID: 10083267
    [No Abstract] [Full Text] [Related]

  • 4. Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.
    Kita Y, Li XK, Ohba M, Funeshima N, Enosawa S, Nogimura H, Ohi S, Kageyama Y, Matsushita K, Ito Y, Takahashi T, Suzuki K, Suzuki S, Kazui T.
    Transplant Proc; 2000 Nov; 32(7):2036-7. PubMed ID: 11120055
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged rat cardiac allograft survival using adenoviral vector containing the CTLA4Ig gene.
    Kita Y, Li XK, Hayashi S, Funeshima N, Enosawa S, Tamura A, Suzuki K, Kazui T, Amemiya H, Suzuki S.
    Transplant Proc; 1998 Jun; 30(4):1079-80. PubMed ID: 9636437
    [No Abstract] [Full Text] [Related]

  • 6. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation.
    Yanagida N, Nomura M, Yamashita K, Takehara M, Murakami M, Echizenya H, Konishi K, Kitagawa N, Furukawa H, Uede T, Todo S.
    Transplant Proc; 2001 Jun; 33(1-2):573-4. PubMed ID: 11266963
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of adenoviral-mediated CTLA4-IG gene-induced pancreatic allograft tolerance in rats.
    Liu C, Deng S, Jiang K, Gelman A, Shaked A, Brayman KL.
    Transplant Proc; 2001 Jun; 33(1-2):134. PubMed ID: 11266743
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of adenovirus-mediated gene transfer with CTLA4Ig in allo and xeno-transplantation.
    Hayashi S, Dai-Kaku L, Namii Y, Kato T, Tokoro T, Kobayashi T, Yokoyama I, Hamada H, Nakao A.
    Transplant Proc; 2000 Nov; 32(7):2520-1. PubMed ID: 11120276
    [No Abstract] [Full Text] [Related]

  • 12. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
    Fu F, Li W, Lu L, Fung JJ, Thomson AW, Qian S.
    Transplant Proc; 1999 Nov; 31(1-2):453. PubMed ID: 10083185
    [No Abstract] [Full Text] [Related]

  • 13. CTLA4-Ig inhibits rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with increased lymphocyte apoptosis.
    Li W, Lu L, Wang Z, Wang L, Thomson A, Fung J, Qian S.
    Transplant Proc; 2001 Nov; 33(1-2):246-7. PubMed ID: 11266801
    [No Abstract] [Full Text] [Related]

  • 14. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA, Peng L, Liang X, Chen Z, Wang L, Ma L, Hackstein H, Robbins PD, Thomson AW, Fung JJ, Qian S, Lu L.
    J Immunol; 2002 Sep 15; 169(6):3382-91. PubMed ID: 12218160
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged survival of heart allograft.
    Hayashi S, Guang-Lin M, Yokoyama I, Namii Y, Hamada H, Nakao A.
    Transpl Int; 2000 Sep 15; 13 Suppl 1():S329-32. PubMed ID: 11112025
    [Abstract] [Full Text] [Related]

  • 16. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF.
    Invest Ophthalmol Vis Sci; 2002 Apr 15; 43(4):1095-103. PubMed ID: 11923251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
    Fu F, Li W, Lu L, Thomson AW, Fung JJ, Qian S.
    Transplant Proc; 1999 Apr 15; 31(1-2):1244. PubMed ID: 10083555
    [No Abstract] [Full Text] [Related]

  • 19. Tolerance to a second donor-matched allograft following local immune modulation using transfer of sequences encoding CTLA4Ig.
    Shaked A, Olthoff K, Sellers M, Chen XD, Gelman A.
    Transplant Proc; 1997 Apr 15; 29(1-2):1026. PubMed ID: 9123180
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of graft coronary arteriosclerosis by gene gun-mediated CTLA4-Ig gene transfer.
    Matsuno Y, Iwata H, Yoshikawa S, Umeda Y, Iida Y, Takagi H, Mori Y, Miyazaki J, Kosugi A, Hirose H.
    Transplant Proc; 2002 Nov 15; 34(7):2619-21. PubMed ID: 12431547
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.